Analysis of Cancer Cell Invasion and Anti-metastatic Drug Screening Using Hydrogel Micro-chamber Array (HMCA)-based

Orit Ravid-Hermesh1, Naomi Zurgil1, Yana Shafran1

  • 1Physics Department, Bar-Ilan University.

Insights

This study introduces a novel 3D cell-based system for analyzing tumor cell invasion, crucial for developing anti-metastatic drugs. The platform allows high-throughput screening of numerous uniform spheroids, advancing cancer research.

Area of Science:

  • Biomedical Engineering
  • Cancer Biology
  • Drug Discovery

Background:

  • Cancer metastasis is a leading cause of cancer-related deaths, with cellular invasion being a critical step.
  • Existing in vitro invasion assays often lack the complexity of in vivo tumor microenvironments or are unsuitable for high-throughput drug screening.
  • There is a need for robust, reproducible 3D in vitro models that mimic solid tumors for effective anti-metastatic drug development.

Purpose of the Study:

  • To develop a simple, biomimetic 3D cell-based system for analyzing tumor spheroid invasion capacity.
  • To enable high-throughput screening of anti-metastatic drugs using a reproducible and scalable assay.
  • To provide a platform for studying tumor invasion mechanisms and evaluating potential therapeutic agents.

Main Methods:

  • Development of a 3D invasion assay using a high-content imaging (HMCA) plate system.
  • Generation of uniform tumor spheroids (HeLa, MCF7) within an extracellular matrix (ECM) environment.
  • Continuous, simultaneous observation and measurement of spheroid invasion using specialized software.

Main Results:

  • The HMCA plate system facilitates the production of numerous uniform spheroids per well, enabling high sample size per condition.
  • The platform successfully demonstrated single-cell and collective invasion of HeLa and MCF7 spheroids.
  • The study quantified the influence of hyaluronic acid (HA) on invasion and validated the system with an invasion inhibitor (Fisetin) and activator (nitric oxide, NO).

Conclusions:

  • The developed 3D invasion assay platform is suitable for medium-throughput screening of anti-metastatic drugs.
  • This biomimetic system offers a reproducible and scalable approach for studying tumor invasion.
  • The platform aids in the multi-parameter examination of invasion dynamics and drug efficacy.

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.8K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
765
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
199
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
553
Chambers of the Heart01:16

Chambers of the Heart

The human heart is a complex organ made up of four chambers: the right and left atria and the right and left ventricles. These internal chambers are separated by partitions known as the interatrial and interventricular septa. The exterior of the heart features a groove known as the coronary sulcus that demarcates the atria from the ventricles, while the anterior and posterior interventricular sulci distinguish between the two ventricles.
Deoxygenated blood from the body is received in the right...
10.5K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.2K